DE
36
-2
AES
41
2
ABT
57
-5
TAP
64
4
XEL
65
-2
XOM
51
3
DRI
56
2
C
62
-3
EMR
77
-2
FOX
57
-3
WFC
80
-2
TXT
62
2
VZ
42
3
PDCO
30
-6
PWR
71
-3
FLR
48
3
ACN
70
5
CMI
67
4
TROW
51
-2
LB
63
-4
DE
36
-2
AES
41
2
ABT
57
-5
TAP
64
4
XEL
65
-2
XOM
51
3
DRI
56
2
C
62
-3
EMR
77
-2
FOX
57
-3
WFC
80
-2
TXT
62
2
VZ
42
3
PDCO
30
-6
PWR
71
-3
FLR
48
3
ACN
70
5
CMI
67
4
TROW
51
-2
LB
63
-4
Financhill
Back

Amicus Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
44

FOLD
Amicus Therapeutics

Last Price:
10.10
Seasonality Move:
8.32%
Sell
32

ALNY
Alnylam Pharmaceuticals

Last Price:
258.10
Seasonality Move:
10.85%
Sell
44
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics a Buy, Sell or Hold?

  • The current Amicus Therapeutics [FOLD] share price is $10.38. The Score for FOLD is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $264.47. The Score for ALNY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FOLD Stock Price Chart

What is Amicus Therapeutics's stock price today?

  • The Amicus Therapeutics share price today is $10.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $264.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

FOLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 36.89 Sell
Chaikin Money Flow: -1470064 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.52 - 11.72) Sell
Bollinger Bands (100): (10.2 - 11.54) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.22 Sell
Relative Strength Index (14 RSI): 40.3 Sell
Chaikin Money Flow: -604310 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (270.63 - 291.59) Sell
Bollinger Bands (100): (248.48 - 281.74) Sell

FOLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.98 Sell
20-day SMA: 11.32 Sell
50-day SMA: 11.06 Sell
200-day SMA: 11.08 Sell
8-day EMA: 10.86 Sell
20-day EMA: 11.06 Sell
50-day EMA: 11.04 Sell
200-day EMA: 11.1 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 271.39 Sell
20-day SMA: 281.16 Sell
50-day SMA: 274.16 Sell
200-day SMA: 209.19 Buy
8-day EMA: 272.22 Sell
20-day EMA: 275.95 Sell
50-day EMA: 272.52 Sell
200-day EMA: 230.17 Buy

Amicus Therapeutics Earnings Growth & FOLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.21 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Amicus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):